<?xml version="1.0" encoding="utf-8"?>
<!-- generator="tx_libfeedcreator" -->
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" ><channel><title>Helmholtz - Press Releases shown on Homepage</title><description>Press Releases shown on Homepage issued by the Helmholtz Association and its Helmholtz Research Centres</description><copyright>Helmholtz-Association</copyright><link>http://www.helmholtz.de/en/press/press_releases/</link><docs>http://www.helmholtz.de/</docs><lastBuildDate>Sat, 12 Jan 2013 12:43:30 +0100</lastBuildDate><managingEditor>presse@helmholtz.de (Thomas Gazlig)</managingEditor><image><url>http://www.helmholtz.de/uploads/tx_a21feeds/HG_LOGO_HELMHOLTZ_140x55_05.gif</url><title>Helmholtz - Press Releases shown on Homepage</title><link>http://www.helmholtz.de/en/press/press_releases/</link></image><language>de</language><webMaster>presse@helmholtz.de (Thomas Gazlig)</webMaster><category>Press</category><category>News</category><category>Press Releases</category><category>Helmholtz</category><category>Helmholtz-Association</category><category>Science</category><generator>tx_libfeedcreator</generator><item><title>Helmholtz International Fellow Award for Craig D. Roberts</title><link>http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2013/13-01-10HGF.html</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Jülich, 10 January 2013 – The physicist Dr. Craig D. Roberts from Argonne National Laboratory, USA, has received the Helmholtz International Fellow Award. This prize worth € 20,000 is awarded by the Helmholtz Association and gives winners an opportunity to organize flexible research stays at one or more Helmholtz centres. Craig D. Roberts is planning to conduct research at the interface of nuclear and particle physics at Forschungszentrum Jülich's Nuclear Physics Institute (IKP) and Institute for Advanced Simulation (IAS). The 50-year-old senior physicist heads the Theory Group at Argonne National Laboratory and is among the most cited nuclear physicists worldwide. He has been cooperating closely with IKP for a number of years, and since 2010, has spent several weeks at Jülich each year as a visiting scientist. The award for Craig D. Roberts also strengthens the new Forces and Matter Experiments section of the Jülich Aachen Research Alliance (JARA-FAME).]]></content:encoded><pubDate>Fri, 11 Jan 2013 13:30:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2013/13-01-10HGF.html</guid></item><item><title>Success for CLIB Graduate Cluster Industrial Biotechnology</title><link>http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2013/13-01-09CLIB.html</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Bielefeld/Dortmund/Düsseldorf/Jülich, 9 January 2013 – Funding has been renewed for the CLIB Graduate Cluster Industrial Biotechnology (CLIB-GC), which was launched in 2009 by Bielefeld University, TU Dortmund University, Heinrich Heine University Düsseldorf and Forschungszentrum Jülich. The cluster will receive funding for a further three years from the Ministry of Innovation, Science and Research of the State of North Rhine-Westphalia as well as from the universities involved.]]></content:encoded><pubDate>Thu, 10 Jan 2013 13:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2013/13-01-09CLIB.html</guid></item><item><title>Award-Winning Research for the Patient</title><link>http://www.dkfz.de/en/presse/pressemitteilungen/2013/dkfz-pm-13-02-Award-Winning-Research-for-the-Patient.php</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[The jury at the German Cancer Research Center (DKFZ) chose two outstanding young researchers, Matthias Eder and Mathias Heikenwälder, whose research findings can be directly translated into clinical practice.]]></content:encoded><pubDate>Wed, 09 Jan 2013 16:02:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dkfz.de/en/presse/pressemitteilungen/2013/dkfz-pm-13-02-Award-Winning-Research-for-the-Patient.php</guid></item><item><title>Award for Indian HZI researcher</title><link>http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/award_for_indian_hzi_researcher/</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Singh Chhatwal receives Pravasi Bharatiya Samman Award 2013. In Kochi, India, the HZI scientist Prof Gursharan Singh Chhatwal was honoured today with the Pravasi Bharatiya Samman Award 2013. With this award, the Indian government dignifies the merits non-resident Indians that have helped to improve the international reputation of India. Chhatwal has continually rendered outstanding services to the Indo-German scientific cooperation. The award was ...]]></content:encoded><pubDate>Wed, 09 Jan 2013 13:30:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/award_for_indian_hzi_researcher/</guid></item><item><title>Scientists Generate Oncolytic Viruses for Targeted Attack on Cancer Stem Cells</title><link>http://www.dkfz.de/en/presse/pressemitteilungen/2013/dkfz-pm-13-02c-Scientists-Generate-Oncolytic-Viruses-for-Targeted-Attack-on-Cancer-Stem-Cells.php</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Researchers from the Paul Ehrlich Institute (PEI) have been the first to generate oncolytic viruses which specifically infect and kill CD133-positive cancer stem cells. Using such viruses, scientists at the German Cancer Research Center (DKFZ) and the National Center for Tumor Diseases (NCT) Heidelberg were able to substantially reduce tumor growth in cell cultures and in an animal model. Cancer Research reports on these research results in its online edition of January 4, 2013.]]></content:encoded><pubDate>Wed, 09 Jan 2013 13:17:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dkfz.de/en/presse/pressemitteilungen/2013/dkfz-pm-13-02c-Scientists-Generate-Oncolytic-Viruses-for-Targeted-Attack-on-Cancer-Stem-Cells.php</guid></item><item><title>Mars500 project – salt balance of the Mars 'astronauts'</title><link>http://www.dlr.de/dlr/presse/en/desktopdefault.aspx/tabid-10172/213_read-5990/</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/ad1980bee1.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/ad1980bee1.jpg" width="200"></span><br />For 205 days in 2011, Jens Titze, Professor of Electrolyte and Circulatory Research at the University of Erlangen-Nuremberg, and his team strictly controlled the diet for the Mars500 test subjects during their virtual flight to Mars. Sometimes the selected food contained a lot of salt, sometimes very little. The unexpected result of the longest sodium metabolism study to date was that the assumption that the human body would excrete the salt within 24 hours was incorrect. Instead, the human body stores salt for much longer before releasing it – an important discovery for medical research and patient care.]]></content:encoded><pubDate>Tue, 08 Jan 2013 17:50:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dlr.de/dlr/presse/en/desktopdefault.aspx/tabid-10172/213_read-5990/</guid></item><item><title>Data Safe for Research</title><link>http://www.kit.edu/visit/pi_2013_12446.php</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Information from former times survived centuries on stone and paper. Modern hard disks, DVDs, and magnetic tapes are less stable and lose reliability after a few years already. However, they are used for the storage of data that have been gathered by modern research projects funded by millions of Euros. In the “Alliance for Research Data Storage” established in the beginning of this year, computer scientists of KIT develop strategies to overcome this dilemma in cooperation with colleagues from Cologne and Göttingen.]]></content:encoded><pubDate>Tue, 08 Jan 2013 00:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.kit.edu/visit/pi_2013_12446.php</guid></item><item><title>Seismic Fabric Coming on the Market</title><link>http://www.kit.edu/visit/pi_2013_12443.php</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/422818bc92.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/422818bc92.jpg" width="200"></span><br />In the case of earthquakes, only seconds may remain for a safe escape from buildings. Debris falling down and obstructing the escape routes may even aggravate the situation. A product developed at Karlsruhe Institute of Technology (KIT) extends the time for saving lifes by reinforcing walls and keeping off the debris. An innovative building material manufacturer now has launched the mature innovation on the market.]]></content:encoded><pubDate>Mon, 07 Jan 2013 00:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.kit.edu/visit/pi_2013_12443.php</guid></item><item><title>Superconductors for Efficient Wind Power Plants</title><link>http://www.kit.edu/visit/12436_12442.php</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/8a6b77036b.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/8a6b77036b.jpg" width="200"></span><br />An efficient, robust, and compact wind power plant with a 10 MW superconducting generator is being developed by partners from industry and science within the recently established EU project SUPRAPOWER. Superconduction enables considerable savings of energy and raw materials. Within SUPRAPOWER, researchers at KIT’s Institute for Technical Physics (ITEP) develop a rotating cryostat cooling the superconducting coils down to minus 253°C - a temperature crucial for electric current flow without resistance.]]></content:encoded><pubDate>Fri, 04 Jan 2013 00:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.kit.edu/visit/12436_12442.php</guid></item><item><title>A Shield Against Cancer</title><link>http://www.dkfz.de/en/presse/pressemitteilungen/2013/dkfz-pm-13-01-A-Shield-Against-Cancer.php</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/6df9229c1a.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/6df9229c1a.jpg" width="200"></span><br />Tumors grow more rapidly if their genetic material is not sufficiently tagged with methyl groups, as scientists from the German Cancer Research Center have discovered. Such tags in the DNA appear to act as a shield against cancer-promoting influences.]]></content:encoded><pubDate>Thu, 03 Jan 2013 11:27:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dkfz.de/en/presse/pressemitteilungen/2013/dkfz-pm-13-01-A-Shield-Against-Cancer.php</guid></item><item><title>Study: Time Pressure Enhances Thrill of Auctions</title><link>http://www.kit.edu/visit/12436_12441.php</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Shopping is more than the rational exchange of goods against money. Emotions, however, do not only play a role when buying a red sports car or the fiftieth pair of shoes. At the stock exchange or during auctions, bidders also are often influenced by irrational motives. In the current issue of the International Journal of Electronic Commerce, KIT scientists point out that the end price of auctions depends on the framework conditions and the emotional pressure of the bidders.]]></content:encoded><pubDate>Thu, 03 Jan 2013 00:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.kit.edu/visit/12436_12441.php</guid></item><item><title>MDC Celebrates Its 20th Anniversary and Plans Berlin Institute of Health</title><link>http://www.mdc-berlin.de/en/news/2012/20121227-mdc_celebrates_its_20th_anniversary_and_pl/index.html</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[In a ceremony under the motto “Research and Responsibility” the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch celebrated its 20th anniversary on Friday, December 7, 2012. Germany’s Education and Research Minister Annette Schavan gave the keynote address in the Max Delbrück Communications Center (MDC.C). Also present at the event were Cornelia Yzer, the Berlin Senator for Economics, Technology and Research, Professor Jürgen Mlynek, President of the Helmholtz Association of which the MDC is a member, and numerous representatives from politics and science.]]></content:encoded><pubDate>Thu, 27 Dec 2012 01:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.mdc-berlin.de/en/news/2012/20121227-mdc_celebrates_its_20th_anniversary_and_pl/index.html</guid></item><item><title>MDC Celebrates Its 20th Anniversary and Plans Berlin Institute of Health</title><link>http://www.mdc-berlin.de/en/news/archive/2012/20121227-mdc_celebrates_its_20th_anniversary_and_pl/index.html</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[In a ceremony under the motto “Research and Responsibility” the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch celebrated its 20th anniversary on Friday, December 7, 2012. Germany’s Education and Research Minister Annette Schavan gave the keynote address in the Max Delbrück Communications Center (MDC.C). Also present at the event were Cornelia Yzer, the Berlin Senator for Economics, Technology and Research, Professor Jürgen Mlynek, President of the Helmholtz Association of which the MDC is a member, and numerous representatives from politics and science.]]></content:encoded><pubDate>Thu, 27 Dec 2012 01:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.mdc-berlin.de/en/news/archive/2012/20121227-mdc_celebrates_its_20th_anniversary_and_pl/index.html</guid></item><item><title>Graphene on Nickel: Electrons behave like light</title><link>http://www.helmholtz-berlin.de/pubbin/news_seite?nid=13643;sprache=en;typoid=3228</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/d77961400c.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/d77961400c.jpg" width="200"></span><br />Dr. Andrei Varykhalov and his colleagues in the group of Prof. Dr. Oliver Rader investigated at BESSY II the electronic properties of nickel coated with graphene and achieved an astonishing result. They could show that the conduction electrons of the graphene behave rather as light than as particles. Physicists had originally expected such behavior only for freestanding graphene layers which show a perfect honeycomb structure and not for graphene on nickel which disturbs the perfect hexagonal symmetry. Their results are supported by calculations of two theoretical groups using novel concepts. Their report was published yesterday evening in the open access journal, Phys. Rev. X, the new top...]]></content:encoded><pubDate>Fri, 21 Dec 2012 10:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.helmholtz-berlin.de/pubbin/news_seite?nid=13643;sprache=en;typoid=3228</guid></item><item><title>DLR researches maritime flight missions using unmanned aircraft systems</title><link>http://www.dlr.de/dlr/presse/en/desktopdefault.aspx/tabid-10172/213_read-5925/</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Reliably monitoring extensive areas of the sea is a major challenge for the coastguard and emergency relief services. Unmanned aircraft are expected to make a critical contribution to this in the future.]]></content:encoded><pubDate>Thu, 20 Dec 2012 08:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dlr.de/dlr/presse/en/desktopdefault.aspx/tabid-10172/213_read-5925/</guid></item><item><title>Field of cancer research continues to expand: new Helmholtz-Zentrum Dresden-Rossendorf Institute of Radiation Oncology opens</title><link>http://www.hzdr.de/db/Cms?pNid=99&amp;pOid=38346</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Am HZDR wird zum 1. Januar 2013 ein neues Institut für Radioonkologie gegründet. Institutsdirektor ist der Dresdner Krebsforscher Prof. Michael Baumann, der auch die Klinik für Strahlentherapie und Radioonkologie am Universitätsklinikum Dresden leitet sowie für das Dresdner OncoRay-Zentrum spricht.]]></content:encoded><pubDate>Thu, 20 Dec 2012 00:00:00 +0100</pubDate><category>HZDR</category><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.hzdr.de/db/Cms?pNid=99&amp;pOid=38346</guid></item><item><title>Field of cancer research continues to expand: new Helmholtz-Zentrum Dresden-Rossendorf Institute of Radiooncology opens</title><link>http://www.hzdr.de/db/Cms?pNid=99&amp;pOid=38346</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Am HZDR wird zum 1. Januar 2013 ein neues Institut für Radioonkologie gegründet. Institutsdirektor ist der Dresdner Krebsforscher Prof. Michael Baumann, der auch die Klinik für Strahlentherapie und Radioonkologie am Universitätsklinikum Dresden leitet sowie für das Dresdner OncoRay-Zentrum spricht.]]></content:encoded><pubDate>Thu, 20 Dec 2012 00:00:00 +0100</pubDate><category>HZDR</category><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.hzdr.de/db/Cms?pNid=99&amp;pOid=38346</guid></item><item><title>Death in the egg: as embryos, shore crabs have nothing to protect themselves against climate change</title><link>http://www.awi.de/en/news/press_releases/detail/item/death_in_the_egg/?cHash=6e98259ab49edba336bb03a9efc25426</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Up to now the shore crab has belonged to those animal species thought by scientists to be more or less immune to climate change. One reason for this was that the crabs are highly tolerant to extremes temperature and feel just as at home in the eight degrees offered by the Atlantic as they do in the 20 degrees warm Mediterranean. A study conducted by German and Italian scientists has now shown, however, that shore crabs react most sensitively to temperature anomalies at certain times of life – as embryos in the egg.]]></content:encoded><pubDate>Wed, 19 Dec 2012 12:26:05 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.awi.de/en/news/press_releases/detail/item/death_in_the_egg/?cHash=6e98259ab49edba336bb03a9efc25426</guid></item><item><title>Interuniversity Options for Geoscience Students</title><link>http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-12-19geoverbund.html</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Aachen, Bonn, Jülich, Cologne, 19 December 2012 – Geoscience students at RWTH Aachen University and the universities of Bonn and Cologne can now take part in lectures and seminars at all three sites free of charge if they are enrolled at one of the universities. This only used to be possible if students were prepared to pay a three-figure sum per semester to register at a second university. The offices of the three rectors have now signed an agreement implementing this innovation. This measure was initiated by the Geoverbund ABC/J, a network comprising Forschungszentrum Jülich, RWTH Aachen University, and the universities of Bonn and Cologne, focusing on the human-earth system in the context of global change.]]></content:encoded><pubDate>Wed, 19 Dec 2012 10:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-12-19geoverbund.html</guid></item><item><title>Preventive Detention for Oxidizing Agents</title><link>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-66-Preventive-Detention-for-Oxidizing-Agents.php</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/00dd10e66d.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/00dd10e66d.jpg" width="200"></span><br />Oxidative stress is believed to cause a number of diseases. Up to now, it has been common practice to measure oxidative stress levels by determining the oxidation state of a small molecule called glutathione in cell extracts. Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have been the first to discover that cells under stress deposit their oxidized glutathione in a cellular waste repository. This protects cells from oxidative stress – and questions the validity of the conventional measuring method.]]></content:encoded><pubDate>Mon, 17 Dec 2012 11:27:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-66-Preventive-Detention-for-Oxidizing-Agents.php</guid></item><item><title>Human against virus – a molecular race</title><link>http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/human_against_virus_a_molecular_race/</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Immunologists discover a novel target to suppress a common virus. Most people become infected with the human cytomegalovirus (CMV) at some point in life. Over millions of years, our immune system has evolved a trick or two to defend us against this virus, but unfortunately, CMV evolved its own tricks, too. New drugs to target viral genes that counter the immune response might support the immune system in the fight against this widespread virus. The idea ...]]></content:encoded><pubDate>Fri, 14 Dec 2012 09:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/human_against_virus_a_molecular_race/</guid></item><item><title>Prestigious Award for Jülich-Aachen Professor Rafal Dunin-Borkowski</title><link>http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-12-14erc-grant.html</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Physicist Rafal Dunin-Borkowski, Professor at Forschungszentrum Jülich and RWTH Aachen University has been awarded a prestigious Advanced Grant from the European Research Council (ERC). The Director at the Ernst Ruska-Centre for Microscopy and Spectroscopy with Electrons will use the funding, worth € 2.5 million over a period of five years, for the development of electron microscopy methods which allow the mapping of magnetic fields in the interior of materials at almost atomic resolution. Fundamental research in the field of nanomagnetism stands to benefit from the success of this project as well as application-oriented research.]]></content:encoded><pubDate>Thu, 13 Dec 2012 14:59:01 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-12-14erc-grant.html</guid></item><item><title>DESY and European XFEL scientists win Innovation Award</title><link>http://www.desy.de/news/@@news-view?id=4221&amp;lang=eng</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/3661d6584f.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/3661d6584f.jpg" width="200"></span><br />Gianluca Geloni, Vitali Kocharyan, and Evgeni Saldin will be awarded the Innovation Award on Synchrotron Radiation by the Association of Friends of Helmholtz-Zentrum Berlin. Together with Paul Emma from Lawrence Berkeley National Laboratory, the physicists from DESY and European XFEL will receive the prize for their invention of a self-seeding option that significantly improves X-ray free-electron lasers.]]></content:encoded><pubDate>Thu, 13 Dec 2012 00:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.desy.de/news/@@news-view?id=4221&amp;lang=eng</guid></item><item><title>Joachim Treusch Receives 2012 Minerva Prize</title><link>http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-12-11minerva.html</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Jülich, 12 December 2012 – Prof. Joachim Treusch has been awarded the 2012 Minerva Prize by Jülich’s Museum Association. Treusch, who served as Chairman of the Board of Directors of Forschungszentrum Jülich for many years, received the award at an evening ceremony in the Schlosskapelle of the Jülich Citadel on 11 December. Prof. Achim Bachem, chairman of the association, paid tribute to his predecessor in the welcoming address, saying, “We are awarding the Minerva Prize to Joachim Treusch in this anniversary year for his outstanding work in bringing together culture and science in the town of Jülich.”]]></content:encoded><pubDate>Wed, 12 Dec 2012 11:30:39 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-12-11minerva.html</guid></item><item><title>Fast20XX research project – ideas for travelling at hypersonic speed</title><link>http://www.dlr.de/dlr/presse/en/desktopdefault.aspx/tabid-10172/213_read-5898/</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[The vision is enticing – board in Europe, sit back, and disembark 90 minutes later on the other side of the world, in Australia. But before the SpaceLiner, which is being developed by the Institute of Space Systems at DLR, can fly a route like this for the first time, new technologies still have to be tested and basic requirements defined.]]></content:encoded><pubDate>Tue, 11 Dec 2012 14:40:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dlr.de/dlr/presse/en/desktopdefault.aspx/tabid-10172/213_read-5898/</guid></item><item><title>Professor Michael Glickman of Technion to Receive Bessel Research Award</title><link>http://www.mdc-berlin.de/en/news/2012/20121211-professor_michael_glickman_of_technion_to_/index.html</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[The chemist Professor Michael Glickman of Technion, the Israel Institute of Technology in Haifa, has been named to receive the Friedrich Wilhelm Bessel Research Award of the Alexander von Humboldt Foundation (AvH) for his outstanding research achievements. With the award, which is endowed with 45,000 euros, Professor Glickman will intensify his long-standing collaboration with the cell biologist Professor Thomas Sommer at the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch, and he will also conduct research at the MDC. The award will be presented to him in the spring of next year.]]></content:encoded><pubDate>Tue, 11 Dec 2012 01:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.mdc-berlin.de/en/news/2012/20121211-professor_michael_glickman_of_technion_to_/index.html</guid></item><item><title>Professor Michael Glickman of Technion to Receive Bessel Research Award</title><link>http://www.mdc-berlin.de/en/news/archive/2012/20121211-professor_michael_glickman_of_technion_to_/index.html</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[The chemist Professor Michael Glickman of Technion, the Israel Institute of Technology in Haifa, has been named to receive the Friedrich Wilhelm Bessel Research Award of the Alexander von Humboldt Foundation (AvH) for his outstanding research achievements. With the award, which is endowed with 45,000 euros, Professor Glickman will intensify his long-standing collaboration with the cell biologist Professor Thomas Sommer at the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch, and he will also conduct research at the MDC. The award will be presented to him in the spring of next year.]]></content:encoded><pubDate>Tue, 11 Dec 2012 01:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.mdc-berlin.de/en/news/archive/2012/20121211-professor_michael_glickman_of_technion_to_/index.html</guid></item><item><title>New insights on phagosome maturation</title><link>http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/new_insights_on_phagosome_maturation/</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/53366cc631.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/53366cc631.jpg" width="200"></span><br />Phagocytes ingest particles as well as pathogens from their surroundings into compartments called phagosomes. The phagosomes possess a harsh milieu with microbicidal function; therefore the phagocytes represent the first line of defense against infections. However, some intracellular pathogens, including members of mycobacterial species, manipulate the phagosomes to survive within them.]]></content:encoded><pubDate>Tue, 11 Dec 2012 00:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/new_insights_on_phagosome_maturation/</guid></item><item><title>Four Top Trainees from Jülich!</title><link>http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-12-10azubis.html</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Jülich, 10 December 2012 – Vanessa Derichs, Carsten Graf, Ingo Heimbach and Florian Rhiem are among the best trainees in Germany. The materials tester, the industrial electrician and the two mathematical and technical software developers from Forschungszentrum Jülich passed their final examinations with the best marks nationwide in their chosen occupations. At a ceremony hosted by the Federal Chamber of Industry and Commerce in Berlin today, together with the other top-ranking trainees, they will be presented with a special award by the Federal Minister for Family Affairs, Kristina Schröder.]]></content:encoded><pubDate>Mon, 10 Dec 2012 15:31:36 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-12-10azubis.html</guid></item><item><title>Working together against Alzheimer's, Parkinson's and dementia</title><link>http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/working_together_against_alzheimers_parkinsons_and_dementia/</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Collaboration between two Helmholtz Centres: Neuroscientists and infection researchers focus on interdisciplinary partnership to study brain diseases. & Two institutions of the Helmholtz Association are joining forces for health research: How does the brain protect itself from pathogens? Can infections favour Alzheimer's disease? Scientists from the German Center for Neurodegenerative Diseases (DZNE) in Bonn and the Helmholtz Centre for Infection Research (HZI) in Braunschweig want to tackle such questions together over the next few ...]]></content:encoded><pubDate>Mon, 10 Dec 2012 10:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/working_together_against_alzheimers_parkinsons_and_dementia/</guid></item><item><title>Working together against Alzheimer‘s, Parkinson‘s and dementia</title><link>http://www.dzne.de/en/about-us/public-relations/meldungen/2012/press-release-no-30.html</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Two institutions of the Helmholtz Association are joining forces for health research: How does the brain protect itself from pathogens? Can infections favour Alzheimer’s disease? Scientists from the German Center for Neurodegenerative Diseases (DZNE) in Bonn and the Helmholtz Centre for Infection Research (HZI) in Braunschweig want to tackle such questions together over the next few years. The interdisciplinary collaboration will receive funding of approximately 600,000 Euro. The researchers hope to discover new facts about dementia and other brain diseases.]]></content:encoded><pubDate>Mon, 10 Dec 2012 00:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dzne.de/en/about-us/public-relations/meldungen/2012/press-release-no-30.html</guid></item><item><title>DLR software unites aircraft engineers</title><link>http://www.dlr.de/dlr/presse/en/desktopdefault.aspx/tabid-10172/213_read-5861/</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Many disciplines are involved in the design and development of an aircraft. To obtain the best combination of wings, fuselage and engines, researchers must work closely together and share their expertise effectively.]]></content:encoded><pubDate>Fri, 07 Dec 2012 11:10:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dlr.de/dlr/presse/en/desktopdefault.aspx/tabid-10172/213_read-5861/</guid></item><item><title>Cocktail Boosts Immune Cells in Fighting Cancer</title><link>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-65-Cocktail-Boosts-Immune-Cells-in-Fighting-Cancer.php</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/6c8e18ab9e.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/6c8e18ab9e.jpg" width="200"></span><br />Natural killer cells (or NK cells), as part of the body´s immune system, can effectively fight cancer. Unfortunately, they quickly lose their aggressiveness and hence are unable to reject solid tumors. Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have now discovered a cocktail consisting of three different immune mediators that leaves NK killer cells active over a long period of time. In mice, cocktail-boosted NK cells let tumors shrink. The cocktail was able to persistently activate human NK cells, too.]]></content:encoded><pubDate>Thu, 06 Dec 2012 10:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-65-Cocktail-Boosts-Immune-Cells-in-Fighting-Cancer.php</guid></item><item><title>New Cooler with Two Million Volts</title><link>http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-12-06Elektronenkuehler.html</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[A new electron cooler for the Jülich particle accelerator COSY has arrived at Forschungszentrum Jülich after a 12-day journey by heavy truck from Novosibirsk nearly 6000 kilometres away. The two-megavolt cooling system developed in cooperation with the Budker Institute of Nuclear Physics will enable COSY to detect extremely rare high-energy decay processes of significance in the search for exotic forms of matter and effects outside the realms of the standard model of particle physics.]]></content:encoded><pubDate>Thu, 06 Dec 2012 09:50:49 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-12-06Elektronenkuehler.html</guid></item><item><title>Tobacco Prevention in Germany  A Success Story with Many Challenges Still Ahead</title><link>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-64-Tobacco-Prevention-in-Germany-A-Success-Story-with-Many-Challenges-Still-Ahead.php</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Smoking is “out”, non-smoking is “in” – particularly among youth: The number of young people trying cigarettes or becoming regular smokers is declining. In the past decade, the smoker´s rate among youth has dropped from 28 percent to less than 12 percent. The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) has brought forward this success in health protection. The WHO Collaborating Centre for Tobacco Control, based at DKFZ, has contributed effective measures for reducing tobacco use to the public debate. In collaboration with other national and international partners it supports decision-makers in implementing such measures.]]></content:encoded><pubDate>Wed, 05 Dec 2012 15:12:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-64-Tobacco-Prevention-in-Germany-A-Success-Story-with-Many-Challenges-Still-Ahead.php</guid></item><item><title>International Research Award for Ingrid Grummt</title><link>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-63-International-Research-Award-for-Ingrid-Grummt.php</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[The French National Institute of Health and Medical Research (Inserm) awards its prestigious “Prix International” to Ingrid Grummt this year. The scientist from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is honored for her life’s work. Grummt studies the role of RNA molecules regulating gene expression.]]></content:encoded><pubDate>Tue, 04 Dec 2012 11:51:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-63-International-Research-Award-for-Ingrid-Grummt.php</guid></item><item><title>How cold will a winter be in two years? New study shows: climate models still struggle with medium- term climate forecasts</title><link>http://www.awi.de/en/news/press_releases/detail/item/how_cold_will_winter_be_in_two_years/?cHash=89449127b8b7525e6c34f4fd9a293237</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[How well are the most important climate models able to predict the weather conditions for the coming year or even the next decade? The Potsdam scientists Dr. Dörthe Handorf and Prof. Dr. Klaus Dethloff from the Alfred Wegener Institute for Polar and Marine Research in the Helmholtz Association (AWI) have evaluated 23 climate models and published their results in the current issue of the international scientific journal Tellus A.]]></content:encoded><pubDate>Tue, 04 Dec 2012 10:37:45 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.awi.de/en/news/press_releases/detail/item/how_cold_will_winter_be_in_two_years/?cHash=89449127b8b7525e6c34f4fd9a293237</guid></item><item><title>Solliance and Forschungszentrum Jülich join forces in thin film solar cell research</title><link>http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-012-03solliance.html</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/d286e3abeb.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/d286e3abeb.jpg" width="200"></span><br />Forschungszentrum Jülich and Solliance announce a new partnership in the field of thin film photovoltaics. Solliance is a cross-border initiative by ECN, imec, Holst Centre, TNO and TU Eindhoven. With Jülich as an additional partner, Solliance grows further as R&D cluster bringing thin film solar energy technology to excellence and is ramping up its activities to gain market share internationally. Some partner companies are successful global players in their segment already. The science and technology in this field are world class in selected areas, with a track record of 15 to 30 years.]]></content:encoded><pubDate>Mon, 03 Dec 2012 15:44:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-012-03solliance.html</guid></item><item><title>Scientists Discover Molecular Switch Involved in Lymphoma</title><link>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-62-Scientists-Discover-Molecular-Switch-Involved-in-Lymphoma.php</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have discovered a molecular switch that plays a role in the development of lymphoma: If a protein called PP4R1 is missing, T cells can divide in an uncontrolled manner, migrate through the body and eventually form skin tumors. The researchers have published their results in the specialist journal “Immunity”.]]></content:encoded><pubDate>Mon, 03 Dec 2012 14:38:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-62-Scientists-Discover-Molecular-Switch-Involved-in-Lymphoma.php</guid></item><item><title>Bonn Neuroscientists Participating in International Initiative for Study of Rare Diseases</title><link>http://www.dzne.de/en/about-us/public-relations/meldungen/2012/press-release-no-28.html</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Scientists from the German Center for Neurodegenerative Diseases (DZNE) are participating in an international research project on the causes of rare degenerative brain and muscle disorders. Over the next five years, the DNZE Bonn site will receive 470,000 euros for the effort. The project, entitled "NEUROMICS: Integrated European Project on Omics Research of Rare Neuromuscular and Neurodegenerative Diseases," is being funded under the EU's Seventh Framework Programme for Research. The partners in the effort hail from Europe, Australia, Canada and the United States. "Such a concerted effort on this scale is unprecedented," explains Prof. Thomas Klockgether, Director of Clinical Research at the DZNE. Relevant work in Bonn will focus on patients and healthy people with increased risks of disease. "We expect the work to yield new findings on the causes of such diseases and to provide impetus for diagnosis and therapy," notes Klockgether.]]></content:encoded><pubDate>Mon, 03 Dec 2012 00:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dzne.de/en/about-us/public-relations/meldungen/2012/press-release-no-28.html</guid></item><item><title>X-ray analysis deciphers master regulator important for skin cancer</title><link>http://www.desy.de/information__services/press/pressreleases/@@news-view?id=4201&amp;lang=eng</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/d456374e19.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/d456374e19.jpg" width="200"></span><br />With the X-ray vision of DESY's light source DORIS, a research team from Hamburg and Iceland has uncovered the molecular structure of a master regulator central to the most deadly form of skin cancer, melanoma. The results, published in the scientific journal "Genes & Development", throw new light on the workings of the so-called Microphthalmia-associated Transcription Factor MITF, that is not only connected to skin cancer, but also to a variety of hereditary diseases where the production of the skin pigment melanin is disturbed, and to certain aspects of ageing. "Our data could provide a rational basis for the development of tailor-made drugs targeting MITF", explains first author Vivian Pogenberg from the Hamburg branch of the European Molecular Biology Laboratory (EMBL).]]></content:encoded><pubDate>Sat, 01 Dec 2012 00:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.desy.de/information__services/press/pressreleases/@@news-view?id=4201&amp;lang=eng</guid></item><item><title>Concentrated competencies in the fight against infectious diseases</title><link>http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/concentrated_competencies_in_the_fight_against_infectious_diseases/</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[HZI and the Robert Koch Institute sign collaboration agreement. Press date: December 6, 3:15 pm. Two leaders in the field of infection research are planning on bundling their expertise in the future. Scientists at the Helmholtz Centre for Infection Research (HZI) in Braunschweig and at the Robert Koch Institute (RKI) in Berlin and Wernigerode will be sharing their resources and potentials to find answers to pressing questions of infection research and epidemiology. The two research institutes' ...]]></content:encoded><pubDate>Fri, 30 Nov 2012 11:58:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/concentrated_competencies_in_the_fight_against_infectious_diseases/</guid></item><item><title>Thomas Hofmann Wins the Prize of the Berlin-Brandenburg Academy of Sciences and Humanities</title><link>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-61-Thomas-Hofmann-Wins-the-Prize-of-the-Berlin-Brandenburg-Academy-of-Sciences-and-Humanities.php</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Dr. Thomas Hofmann, junior research group leader at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), is awarded the €10,000 prize for his outstanding achievements in cancer research. Hofmann, a biologist, unraveled the mechanisms by which cells decide upon their further fate following DNA damage. His findings help to understand how cancer cells respond to therapies involving DNA damage.]]></content:encoded><pubDate>Fri, 30 Nov 2012 11:40:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-61-Thomas-Hofmann-Wins-the-Prize-of-the-Berlin-Brandenburg-Academy-of-Sciences-and-Humanities.php</guid></item><item><title>Molecular knock-out alleviates Alzheimer’s symptoms in mice</title><link>http://www.dzne.de/en/about-us/public-relations/meldungen/2012/press-release-no-27.html</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Researchers at the German Center for Neurodegenerative Diseases (DZNE) and the University Medical Center Göttingen (UMG) have identified an enzyme as a possible target for the treatment of Alzheimer’s disease. The protein known as HDAC6 impairs transport processes within the nerve cells. The scientists observed only mild symptoms of the disease in mice if the enzyme was not produced. They propose to block its activity in a targeted fashion to treat the disease. Scientists from the DZNE sites in Göttingen and Bonn, the UMG as well as from the US participated in this basic research project on Alzheimer’s disease. The study is published in "EMBO Molecular Medicine".]]></content:encoded><pubDate>Fri, 30 Nov 2012 00:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dzne.de/en/about-us/public-relations/meldungen/2012/press-release-no-27.html</guid></item><item><title>Traffic Cops of the Immune System</title><link>http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/traffic_cops_of_the_immune_system/</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/1fd84ec85b.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/1fd84ec85b.jpg" width="200"></span><br />Molecule called IκBNS in charge of regulatory immune cell maturation. A certain type of immune cell – the regulatory T cell, or Treg for short – is in charge of putting on the brakes on the immune response. In a way, this cell type might be considered the immune system"s traffic cop. Now, scientists at the Helmholtz Centre for Infection Research (HZI) have looked into the origin of Tregs and uncovered a central role played by the protein IκBNS.]]></content:encoded><pubDate>Thu, 29 Nov 2012 18:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/traffic_cops_of_the_immune_system/</guid></item><item><title>HZI part of COMPACT</title><link>http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/hzi_part_of_compact/</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Public-private partnership for research of new pharmceutics. The Helmholtz Centre for Infection Research (HZI) and its branch Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) are partners in & the project& COMPACT (Collaboration on the Optimisation of Macromolecular Pharmaceutical Access to Cellular Targets), initiated by the pharma company Sanofi. Thirteen further& academic research facilities, six pharmaceutical companies ...]]></content:encoded><pubDate>Thu, 29 Nov 2012 16:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/hzi_part_of_compact/</guid></item><item><title>New approach allows past data to be used to improve future climate projections</title><link>http://www.awi.de/en/news/press_releases/detail/item/new_approach_allows_past_data_to_be_used_to_improve_future_climate_projections/?cHash=63fb25d9eaada95414ce6ab335ca2a13</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Climate scientists are still grappling with one of the main questions of modern times: how high will global temperatures rise if the atmospheric concentration of carbon dioxide doubles. Many researchers are now turning to the past because it holds clues to how nature reacted to climate change before the anthropogenic impact. The divergent results of this research, however, have made it difficult to make precise predictions about the impact of increased carbon dioxide on future warming. An international team of scientists have evaluated previously published estimates and assigned them consistent categories and terminology.]]></content:encoded><pubDate>Thu, 29 Nov 2012 13:44:05 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.awi.de/en/news/press_releases/detail/item/new_approach_allows_past_data_to_be_used_to_improve_future_climate_projections/?cHash=63fb25d9eaada95414ce6ab335ca2a13</guid></item><item><title>Astrium to build two new research satellites GRACE-FO</title><link>http://www.gfz-potsdam.de/portal/gfz/Public+Relations/Pressemitteilungen/aktuell/121129_GraceFO</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Astrium, Europe’s leading space technology company, has been commissioned to build two new research satellites for NASA’s Jet Propulsion Laboratory JPL (Pasadena, California). The agreement was signed today in Friedrichshafen, Germany. For a minimum of five years from August 2017, the Gravity Recovery and Climate ExperimentFollow-On (Grace FO) mission will continue the extremely accurate measurement data collection of the first twin Grace satellites, which have been in orbit since 17 March, 2002.]]></content:encoded><pubDate>Thu, 29 Nov 2012 02:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.gfz-potsdam.de/portal/gfz/Public+Relations/Pressemitteilungen/aktuell/121129_GraceFO</guid></item><item><title>X-rays expose blueprint for possible sleeping sickness drug</title><link>http://www.desy.de/information__services/press/pressreleases/@@news-view?id=4161&amp;lang=eng</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Using the world's most powerful X-ray laser, scientists have exposed a possible Achilles' heel of the sleeping sickness parasite that threatens more than 60 million people in sub-Saharan Africa. The sophisticated analysis revealed the blueprint for a molecular plug that can selectively block a vital enzyme of the parasite Trypanosoma brucei. Plugging such a tailor-made molecule into the right place of the enzyme would render it inactive, thereby killing the parasite. The team led by DESY scientist Prof. Henry Chapman from the Center of Free-Electron Laser Science (CFEL), Prof. Christian Betzel from the University of Hamburg and Dr. Lars Redecke from the joint Junior Research Group "Structural Infection Biology using new Radiation Sources (SIAS)" of the Universities of Hamburg and Lübeck report their findings in the journal "Science". "This is the first new biological structure solved with a free-electron laser," said Chapman.]]></content:encoded><pubDate>Thu, 29 Nov 2012 00:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.desy.de/information__services/press/pressreleases/@@news-view?id=4161&amp;lang=eng</guid></item><item><title>Asteroid dust from space</title><link>http://www.dlr.de/dlr/presse/en/desktopdefault.aspx/tabid-10172/213_read-5773/</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/d6cb230eeb.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/d6cb230eeb.jpg" width="200"></span><br />To the naked eye there is nothing to see, and yet the small transparent container holds something never observed before. For the first time, scientists are studying asteroid dust collected by a spacecraft and returned to Earth. Ute Böttger, from the Institute of Planetary Research at the German Aerospace Center (Deutsches Zentrum für Luft- und Raumfahrt; DLR), belongs to one of 11 teams across the world that are carrying out scientific work on the asteroid particles from the Japanese Hayabusa mission.]]></content:encoded><pubDate>Wed, 28 Nov 2012 14:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dlr.de/dlr/presse/en/desktopdefault.aspx/tabid-10172/213_read-5773/</guid></item><item><title>How Aggregated Proteins Can Return to Their Original Shape</title><link>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-58c-How-Aggregated-Proteins-CanReturn-to-Their-Original-Shape.php</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Anybody knows the process that happens when you cook an egg: The initially liquid and transparent egg white turns solid and opaque. Heidelberg scientists from the Center for Molecular Biology (ZMBH) at Heidelberg University and the German Cancer Research Center (DKFZ) have now discovered and unraveled a repair system used by cells to revert this protein aggregation. Experts from the Heidelberg Institute for Theoretical Studies (HITS) also participated in the research project. The scientists have now reported their research results in two simultaneously published articles in the specialist journal “Nature Structural and Molecular Biology”.]]></content:encoded><pubDate>Wed, 28 Nov 2012 13:29:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-58c-How-Aggregated-Proteins-CanReturn-to-Their-Original-Shape.php</guid></item><item><title>Multiplexion Assures Quality of Research Results - Spinout from German Cancer Research Center checks cell cultures for contamination</title><link>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-60-Multiplexion-Assures-Quality-of-Research-Results.php</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Contamination of cell cultures by bacteria, viruses or other cells is a widespread problem in biomedical research. The company Multiplexion, a spinout from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), checks cell cultures of clients from research institutes and companies for many different types of contamination and verifies the identity of cell lines. The test is quick and low-cost and contributes to quality assurance and reproducibility of biomedical research results.]]></content:encoded><pubDate>Wed, 28 Nov 2012 11:21:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-60-Multiplexion-Assures-Quality-of-Research-Results.php</guid></item><item><title>Graphene switches: HZB research group makes it to first base</title><link>http://www.helmholtz-berlin.de/pubbin/news_seite?nid=13624;sprache=en;typoid=3228</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Ever since graphene was first isolated a few years ago, this quasi-two-dimensional network made up of a single layer of carbon atoms has been considered the magic material. Not only is graphene mechanically highly resilient, it also provides an interesting basis for new spintronic components that exploit the magnetic moment of conduction electrons. Now, Helmholtz Centre Berlins Dr. Andrei Varykhalov, Prof. Dr. Oliver Rader and his team of physicists has taken the first step towards building graphene-based components, in collaboration with physicists from St. Petersburg (Russia), Jülich (Germany) and Harvard (USA). According to their report on 27th November 2012 in Nature Communications (...]]></content:encoded><pubDate>Tue, 27 Nov 2012 10:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.helmholtz-berlin.de/pubbin/news_seite?nid=13624;sprache=en;typoid=3228</guid></item><item><title>Sieve holds nanoparticles and acts as solar absorber</title><link>http://www.hzg.de/cms01/public_relations/press_releases/034817/index_0034817.html.en</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/a54e5381c9.jpeg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/a54e5381c9.jpeg" width="200"></span><br />A membrane consisting of polymer fibres and proteins makes a novel filter for tiny, nano-scaled particles in aqueous solutions. The result of such a research, which was done by Professor Mady Elbahri and his team from the Institute of Material Science at the Christian Albrecht University University in Kiel (CAU) and the Institue of Polymer Research at the Helmholtz-Zentrum Geestacht (HZG), has recently been published as the cover article in the current issue (21.11.2012) of "Advanced Functional Materials".]]></content:encoded><pubDate>Tue, 27 Nov 2012 09:13:44 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.hzg.de/cms01/public_relations/press_releases/034817/index_0034817.html.en</guid></item><item><title>First UNEP Permafrost Report relies on expertise of the Alfred Wegener Institute</title><link>http://www.awi.de/en/news/press_releases/detail/item/first_unep_permafrost_report_relies_on_expertise_of_the_alfred_wegener_institute/?cHash=eeb309d688386dab06527984352396f5</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[For the first time the United Nations Environment Programme (UNEP) has today published a Report on the status of the global permafrost regions. In it an international team of experts clearly explains how climate change is impacting the permanently frozen soils in the Arctic, Siberia and in the high mountain regions, which potential hazards emanate from the thawing ground and the far-reaching consequences countries with permafrost must consider. The researchers also call upon politicians and climate scientists to include the knowledge about the change in the permafrost regions to a greater extent in the international climate debate. “The Report shows that in future the change in the permafr]]></content:encoded><pubDate>Tue, 27 Nov 2012 08:41:45 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.awi.de/en/news/press_releases/detail/item/first_unep_permafrost_report_relies_on_expertise_of_the_alfred_wegener_institute/?cHash=eeb309d688386dab06527984352396f5</guid></item><item><title>Searching for Clues in Leukemia Genomes: Charles G. Mullighan Wins 2012 Meyenburg Award</title><link>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-59-Searching-for-Clues-in-Leukemia-Genomes-Charles-Mullighan-Wins-2012-Meyenburg-Award.php</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[The 2012 Meyenburg Award of €50,000 goes to physician and researcher Charles G. Mullighan. He is distinguished for his outstanding work in the field of identifying genetic changes leading to the onset of leukemia. Mullighan systematically analyzed tumor genomes of blood cancer cells in order to find new methods for treating children suffering from leukemia. The Meyenburg Award will be presented on Tuesday, November 27, 2012 at a symposium held at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ).]]></content:encoded><pubDate>Mon, 26 Nov 2012 16:15:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-59-Searching-for-Clues-in-Leukemia-Genomes-Charles-Mullighan-Wins-2012-Meyenburg-Award.php</guid></item><item><title>MAPHEUS-3: Flight-testing furnaces in microgravity</title><link>http://www.dlr.de/dlr/presse/en/desktopdefault.aspx/tabid-10172/213_read-5707/</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[There are very few ways of conducting experiments without the influence of Earth's gravity. One of these platforms became available on 25 November 2012, when a rocket was launched from the Swedish Esrange Space Center in Kiruna.]]></content:encoded><pubDate>Mon, 26 Nov 2012 16:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dlr.de/dlr/presse/en/desktopdefault.aspx/tabid-10172/213_read-5707/</guid></item><item><title>Six Dimensions for Increased Safety</title><link>http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-11-22beckurts-stiftung.html</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Daimler Research Team Awarded 2012 Beckurts Prize for New Intelligent Driver Assistance System Munich, 26 November 2012 – This year's Karl Heinz Beckurts Prize will be presented on Monday, 26 November, to Dr. Uwe Franke, Dr. Stefan Gehrig and Dr. Clemens Rabe. The three researchers from Daimler AG will receive the prize, endowed with € 30,000, for their "6D Vision", which will in future assist drivers in very complex traffic environments with restricted visibility such as construction sites and intersections. This will make a decisive contribution towards accident reduction.]]></content:encoded><pubDate>Mon, 26 Nov 2012 09:35:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-11-22beckurts-stiftung.html</guid></item><item><title>Combination of two pharmaceuticals proves effective in the treatment of multiple sclerosis</title><link>http://www.dzne.de/en/about-us/public-relations/meldungen/2012/press-release-no-26.html</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[A new substance class for the treatment of multiple sclerosis and other neurodegenerative diseases now promises increased efficacy paired with fewer side effects. To achieve this, a team of scientists under the leadership of Prof. Gunter Fischer (Max Planck Research Unit for Enzymology of Protein Folding, Halle/Saale, Germany) and Dr. Frank Striggow (German Center for Neurodegenerative Diseases (DZNE)) have combined two already approved pharmaceutical substances with each other using a chemical linker structure. The objectives of this combination are to ensure maximum brain cell protection on the one hand and the suppression of unwanted side effects on the other. The new class of substances has now been registered with the European Patent Office as the DZNE’s first patent in the form of a joint patent application with the Max Planck Research Unit. “The patent approval process can take several years. During this phase we are planning to conclude the pre-clinical development. It is our aim to start with clinical research and development at the earliest possible time. Overall, we have identified substantial therapeutic potential as far as chronic and age-related neurodegenerative diseases are concerned,” comments Dr. Frank Striggow.]]></content:encoded><pubDate>Mon, 26 Nov 2012 00:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dzne.de/en/about-us/public-relations/meldungen/2012/press-release-no-26.html</guid></item><item><title>Climate change evident across Europe, confirming urgent need for adaptation</title><link>http://www.ufz.de/index.php?en=31034</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Climate change is affecting all regions in Europe, causing a wide range of impacts on society and the environment. Further impacts are expected in the future, potentially causing high damage costs, according to the latest assessment published by the European Environment Agency today.]]></content:encoded><pubDate>Fri, 23 Nov 2012 01:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.ufz.de/index.php?en=31034</guid></item><item><title>DZNE scientist receives the Alzheimer Research Award of the Hans and Ilse Breuer Foundation</title><link>http://www.dzne.de/en/about-us/public-relations/meldungen/2012/press-release-no-25.html</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Prof. Thomas Misgeld from the German Center for Neurodegenerative Diseases (DZNE) as well as the Technischen Universität München and Prof. Boris Schmidt, Technische Universität Darmstadt, have been awarded with the 2012 Hans and Ilse Breuer Foundation Alzheimer Research Award. The prize money totals 100,000 EUR and will be shared between the two scientists. The award ceremony took place on the 21st of November as part of the Eibsee Meeting “Cellular mechanisms of neurodegeneration”. “We congratulate Thomas Misgeld for receiving this prestigious award“, notes Prof. Pierluigi Nicotera, Scientific Director and Chairman of the Executive Board of the DZNE.]]></content:encoded><pubDate>Fri, 23 Nov 2012 00:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dzne.de/en/about-us/public-relations/meldungen/2012/press-release-no-25.html</guid></item><item><title>New Risk Factor Identified for High Blood Pressure during Pregnancy</title><link>http://www.mdc-berlin.de/en/news/archive/2012/20121122-new_risk_factor_identified_for_high_blood_/index.html</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Preeclampsia is a serious complication of pregnancy and the major cause of death for both mother and child in Europe and the U.S. It affects about one in 20 pregnancies. The main symptoms are high blood pressure and protein in the urine. The cause of preeclampsia is still unclear. Dr. Florian Herse (Experimental and Clinical Research Center (ECRC) of the Max Delbrück Center (MDC) and the Charité), Dr. Ralf Dechend (ECRC and Helios Klinikum Berlin-Buch) and their collaborators have now identified an enzyme that is overexpressed in affected women and thus apparently contributes to development of the condition. In animal experiments, the researchers inhibited this enzyme and were able to ameliorate the disease process (10.1161/CIRCULATIONAHA.112.127340)*.]]></content:encoded><pubDate>Thu, 22 Nov 2012 01:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.mdc-berlin.de/en/news/archive/2012/20121122-new_risk_factor_identified_for_high_blood_/index.html</guid></item><item><title>Six patients fall ill with the new corona virus</title><link>http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/six_patients_fall_ill_with_the_new_corona_virus/</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Update from 23 November 2012. Press information of the German Centre for Infection Research& On Friday, the World Health Organization (WHO) reported further cases of illness caused by the new corona virus; the number of laboratory-confirmed cases has thus risen to a total of six, four patients originating from Saudi Arabia and two from Qatar. Two of the four patients from Saudi Arabia have died. The two patients ...]]></content:encoded><pubDate>Wed, 21 Nov 2012 21:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/six_patients_fall_ill_with_the_new_corona_virus/</guid></item><item><title>Germany consolidates its position in European space</title><link>http://www.dlr.de/dlr/presse/en/desktopdefault.aspx/tabid-10172/213_read-5723/</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[On 20 and 21 November 2012, delegates from the 20 member states of the European Space Agency (ESA) and Canada met at the 'Mostra d'Oltremare' conference centre in Naples, Italy.]]></content:encoded><pubDate>Wed, 21 Nov 2012 17:20:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dlr.de/dlr/presse/en/desktopdefault.aspx/tabid-10172/213_read-5723/</guid></item><item><title>Coastal research on a big screen ? Event ?13. Lüneburger Umweltfilmtage?</title><link>http://www.hzg.de/cms01/public_relations/press_releases/034804/index_0034804.html.en</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Ferry boats in the service of science: On Sunday, 25/11/2012 you can watch a new video about the FerryBox in the cinema ?Lüneburger Scala-Programmkino? for the first time.]]></content:encoded><pubDate>Wed, 21 Nov 2012 15:39:43 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.hzg.de/cms01/public_relations/press_releases/034804/index_0034804.html.en</guid></item><item><title>Coastal research on a big screen - Event "13. Lüneburger Umweltfilmtage"</title><link>http://www.hzg.de/cms01/public_relations/press_releases/034804/index_0034804.html.en</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Ferry boats in the service of science: On Sunday, 25/11/2012 you can watch a new video about the FerryBox in the cinema ?Lüneburger Scala-Programmkino? for the first time.]]></content:encoded><pubDate>Wed, 21 Nov 2012 15:36:49 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.hzg.de/cms01/public_relations/press_releases/034804/index_0034804.html.en</guid></item><item><title>KIT Will Consistently and Determinedly Continue along Its Path</title><link>http://www.kit.edu/visit/pi_2012_12249.php</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[More than 300 million euros of third-party funding, 430 completed doctorates, 23700 students: These figures show that Karlsruhe Institute of Technology (KIT) continues to grow. The review of the year presented by KIT President Eberhard Umbach at the Annual Academic Celebration focused on recent successes of KIT scientists, future challenges as well as on the results of the Excellence Initiative.]]></content:encoded><pubDate>Wed, 21 Nov 2012 02:12:11 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.kit.edu/visit/pi_2012_12249.php</guid></item><item><title>Helmholtz Day in JuLab at Forschungszentrum Jülich</title><link>http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-11-20JuLab.html</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[School students from Ernst Mach Gymnasium in Hürth spent today at the JuLab schools laboratory to celebrate the first Helmholtz Day. The 25 schools laboratories in the Helmholtz Association, of which Forschungszentrum Jülich is also a member, have initiated this day to commemorate Hermann von Helmholtz (1821 - 1894). The Helmholtz Association takes its name from this leading 19th century scientist. From now on, Helmholtz Day will be celebrated once a year in November.]]></content:encoded><pubDate>Tue, 20 Nov 2012 10:30:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-11-20JuLab.html</guid></item><item><title>New Risk Factor Identified for High Blood Pressure during Pregnancy</title><link>http://www.mdc-berlin.de/en/news/2012/20121122-new_risk_factor_identified_for_high_blood_/index.html</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Preeclampsia is a serious complication of pregnancy and the major cause of death for both mother and child in Europe and the U.S. It affects about one in 20 pregnancies. The main symptoms are high blood pressure and protein in the urine. The cause of preeclampsia is still unclear. Dr. Florian Herse (Experimental and Clinical Research Center (ECRC) of the Max Delbrück Center (MDC) and the Charité), Dr. Ralf Dechend (ECRC and Helios Klinikum Berlin-Buch) and their collaborators have now identified an enzyme that is overexpressed in affected women and thus apparently contributes to development of the condition. In animal experiments, the researchers inhibited this enzyme and were able to ameliorate the disease process (10.1161/CIRCULATIONAHA.112.127340)*.]]></content:encoded><pubDate>Mon, 19 Nov 2012 01:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.mdc-berlin.de/en/news/2012/20121122-new_risk_factor_identified_for_high_blood_/index.html</guid></item><item><title>Profiling X-ray free-electron laser pulses</title><link>http://www.desy.de/information__services/press/pressreleases/@@news-view?id=4061&amp;lang=eng</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/868d33800e.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/868d33800e.jpg" width="200"></span><br />With their ultra short X-ray flashes, free-electron lasers offer the opportunity to film chemical reactions or atoms in motion. However, for this super slow motion the arrival time and the temporal profile of the pulses must be precisely known. An international team of scientists has now developed a measurement technique that provides complete temporal characterization of individual FEL (free-electron laser) pulses at DESY´s soft-X-ray free-electron laser FLASH. The team, led by Adrian Cavalieri from the Center for Free-Electron Laser Science (CFEL) in Hamburg, was able to measure the temporal profile of each X-ray pulse with femtosecond precision (a femtosecond is a quadrillionth of a second). Their technique can be implemented at any of the world´s X-ray free-electron lasers, ultimately allowing for most effective utilization of these sources. The results are published in the current issue of the scientific journal &ldquo;Nature Photonics&rdquo;.]]></content:encoded><pubDate>Mon, 19 Nov 2012 00:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.desy.de/information__services/press/pressreleases/@@news-view?id=4061&amp;lang=eng</guid></item><item><title>Science and industry join forces to optimize cancer treatment</title><link>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-58b-Science-and-industry-join-forces-to-optimize-cancer-treatment.php</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Roche has concluded its first collaborative agreement on personalized healthcare with the National Center for Tumor Diseases (NCT), represented by its supporting institutions, the German Cancer Research Center (DKFZ) and Heidelberg University Hospital. The aim is to strengthen cooperation between all participating partners in the early stages of oncology research and development projects so that patients reap benefit from innovations sooner. Two projects are already underway. Joint press release of German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Roche, Heidelberg University Hospital (Universitätsklinikum Heidelberg) and National Center for Tumor Diseases (Nationales Centrum für Tumorerkrankungen, NCT)]]></content:encoded><pubDate>Fri, 16 Nov 2012 15:09:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-58b-Science-and-industry-join-forces-to-optimize-cancer-treatment.php</guid></item><item><title>Appetite suppressant for scavenger cells</title><link>http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/appetite_suppressant_for_scavenger_cells/</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/fb9cc10763.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/fb9cc10763.jpg" width="200"></span><br />When infected with influenza, the body becomes an easy target for bacteria. The flu virus alters the host’s immune system and compromises its capacity to effectively fight off bacterial infections. Now, a team of immunologists at the Helmholtz Centre for Infection Research (HZI) and cooperation partners has discovered that an immune system molecule called TLR7 is partly to blame. The molecule recognizes the viral genome – and then signals scavenger cells of the immune system to ingest fewer bacteria. The researchers published their findings in the Journal of Innate Immunity.]]></content:encoded><pubDate>Thu, 15 Nov 2012 10:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/appetite_suppressant_for_scavenger_cells/</guid></item><item><title>Chances of the use of geothermal energy in urban areas</title><link>http://www.gfz-potsdam.de/portal/gfz/Public+Relations/Pressemitteilungen/aktuell/121115_Geothermie_Bruessel</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Today in Brussels a workshop was held on the future role of geothermal energy in Europe's heat supply, initiated by the European Commission. The event "Future Utilization of Geothermal Energy in Urban Areas" concerning geothermal power and heat production in urban areas also featured the European Commissioner Günther H. Oettinger as a speaker. It was organized by two member centres of the Helmholtz Association, the Karlsruhe Institute of Technology (KIT) and the Helmholtz Centre Potsdam - GFZ German Research Centre for Geosciences.]]></content:encoded><pubDate>Thu, 15 Nov 2012 02:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.gfz-potsdam.de/portal/gfz/Public+Relations/Pressemitteilungen/aktuell/121115_Geothermie_Bruessel</guid></item><item><title>The potential for using geothermal energy in urban areas</title><link>http://www.helmholtz.de/en/press/press_releases/artikel/artikeldetail/chancen_der_nutzung_von_geothermie_in_staed_tischen_ballungsraeumen/</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/6346819cd2.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/6346819cd2.jpg" width="200"></span><br />A workshop on the future role of geothermal energy in supplying heat in Europe took place in Brussels today on the initiative of the European Commission.  The European Workshop on Future Utilization of Geothermal Energy in Urban Areas addressed the use of geothermal energy in generating heat and electricity in towns and cities and included a speech by EU Energy Commissioner Günther Oettinger. The event was organised by two Helmholtz Centres: the Karlsruhe Institute of Technology (KIT) and the Helmholtz Centre Potsdam ‒ German Research Centre for Geosciences (GFZ).]]></content:encoded><pubDate>Thu, 15 Nov 2012 00:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.helmholtz.de/en/press/press_releases/artikel/artikeldetail/chancen_der_nutzung_von_geothermie_in_staed_tischen_ballungsraeumen/</guid></item><item><title>Smoking affects allergy-relevant stem cells</title><link>http://www.ufz.de/index.php?en=30928</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Environmental contaminants, such as smoking, are harmful to the human organism in relation to the occurrence of allergies. This is known. Until now, researchers had never investigated whether and to what extent environmental contaminants also affect allergy-relevant stem cells. For the first time a team at the Helmholtz Centre for Environmental Research (UFZ) has found evidence for this: Smoking affects the development of peripheral allergy-relevant stem cells in the blood. In order to present this result Dr. Irina Lehmann and Dr. Kristin Weiße chose a new scientific path: The combination of exposure analysis and stem cell research.]]></content:encoded><pubDate>Wed, 14 Nov 2012 01:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.ufz.de/index.php?en=30928</guid></item><item><title>New Fusion Research Building Opened</title><link>http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-11-13fusion.html</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[The new building for plasma physics at Forschungszentrum Jülich was officially opened today by representatives from politics and science. Jülich scientists working in this field are involved in coordinated efforts worldwide to create power plants based on nuclear fusion. The new building, constructed at a cost of € 4.6 million, provides office space and additional laboratory facilities.]]></content:encoded><pubDate>Tue, 13 Nov 2012 17:24:43 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-11-13fusion.html</guid></item><item><title>Disrupted Signaling and Disease: International Metabolism Conference at the German Cancer Research Center</title><link>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-58-Disrupted-Signaling-and-Disease.php</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Scientists from around the globe will convene at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) on November 15th – 16th, 2012 to discuss the links between a disrupted metabolism and various diseases. The conference “Metabolism 2012: From Signaling to Disease” is part of an annual forum series organized in Heidelberg by the DKFZ-ZMBH Alliance, which is a strategic alliance between the German Cancer Research Center (DKFZ) and the Center for Molecular Biology (ZMBH) at Heidelberg University. Professor Stephan Herzig, who heads a joint research department of DKFZ, ZMBH and Heidelberg University Hospital on diabetes and cancer, leads conference organization.]]></content:encoded><pubDate>Tue, 13 Nov 2012 15:20:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-58-Disrupted-Signaling-and-Disease.php</guid></item><item><title>Physicists simulate the effects of thermal fluctuations</title><link>http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-11-12Thermische_Fluktuationen.html</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[At what pressure do thin shells start to collapse? This classical mechanical problem also plays a part in understanding microcapsules, which are used to transport active ingredients directly to an organ in the body. In contrast to pressure vessels or diving bells, thermal fluctuations also exert an influence here. The microscopic shells are deformed in an uncontrolled manner due to this thermally induced molecular motion. Under pressure, these shells therefore tend to collapse at an earlier stage than predicted, which was revealed for the first time in precise calculations made by Jülich scientists and their partners from Harvard University. Their findings have been published in the renowned journal PNAS.]]></content:encoded><pubDate>Tue, 13 Nov 2012 14:39:41 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-11-12Thermische_Fluktuationen.html</guid></item><item><title>Searching for Defects in Cancer Cell Genomes:</title><link>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-57-Searching-for-Defects-in-Cancer-Cell-Genomes.php</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[An interdisciplinary German research network with major participation of researchers from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) has sequenced the complete genome of Burkitt lymphoma cancer cells. In their project as part of the International Cancer Genome Consortium (ICGC), the scientists found the genome of Burkitt lymphoma tumor cells mutated in more than 2,000 spots compared to normal cells. The researchers discovered a gene mutated in more than three thirds of all Burkitt lymphomas. This provides new targets for diagnosis and therapy of this aggressive type of lymphoma. The giant amount of data generated in this project is stored and evaluated at DKFZ, where Prof. Roland Eils has been building up a bioinformatics infrastructure for cancer genome sequencing unique in Germany. The results have now been published in the journal Nature Genetics.]]></content:encoded><pubDate>Mon, 12 Nov 2012 15:07:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-57-Searching-for-Defects-in-Cancer-Cell-Genomes.php</guid></item><item><title>Europe's Queen of the Computers</title><link>http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-11-12juqueen.html</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/09bcae9e77.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/09bcae9e77.jpg" width="200"></span><br />The new high performance Computer JUQUEEN at Forschungszentrum Juelich has reached the new top position as Europe's fastest supercomputer and 5th fastest in the world by the current TOP500 List, published recently. As the first supercomputer in Europe to reach a compute performance of 5 Petaflop/s – equating to 5 quadrillion operations per second – the system opens up new possibilities for research intensive grand projects and a wider spectrum of participating work groups.]]></content:encoded><pubDate>Mon, 12 Nov 2012 15:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-11-12juqueen.html</guid></item><item><title>36 in one fell swoop – researchers observe “impossible” ionization</title><link>http://www.desy.de/information__services/press/pressreleases/@@news-view?id=3981&amp;lang=eng</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/fe07888a7c.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/fe07888a7c.jpg" width="200"></span><br />Using the world&rsquo;s most powerful X-ray laser in California, an international research team discovered a surprising behaviour of atoms: with a single X-ray flash, the group led by Daniel Rolles from the Center for Free-Electron Laser Science (CFEL) in Hamburg (Germany) was able to kick a record number of 36 electrons at once out of a xenon atom. According to theoretical calculations, these are significantly more than should be possible at this energy of the X-ray radiation. The team present their unexpected observations in the journal &ldquo;Nature Photonics&rdquo;. CFEL is a collaboration of DESY, the Max Planck Society and the University of Hamburg.]]></content:encoded><pubDate>Sun, 11 Nov 2012 00:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.desy.de/information__services/press/pressreleases/@@news-view?id=3981&amp;lang=eng</guid></item><item><title>Polymer workshop in Geesthacht: New forum for polymer experts</title><link>http://www.hzg.de/cms01/public_relations/press_releases/034606/index_0034606.html.en</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[The Institute of Polymer Research at the Helmholtz-Zentrum Geesthacht organises a workshop for scientists in industry and at universities on November 13th and 14th. An introduction into the mechanical and rheological properties of polymer materials and an extensive insight into the application methods of the rheology and mechanics of polymers in practice will be presented by experts from industry and research.]]></content:encoded><pubDate>Fri, 09 Nov 2012 09:27:31 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.hzg.de/cms01/public_relations/press_releases/034606/index_0034606.html.en</guid></item><item><title>A "finger" pointing the way to new hepatitis C medication</title><link>http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/a_finger_pointing_the_way_to_new_hepatitis_c_medication/</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Some 160 million men and women are infected with hepatitis C virus (HCV), the most common cause of cirrhosis and cancer of the liver. The present standard therapy is thraught with serious side-effects leading to a cure in only half of the patients. New therapies utilise small molecules that inhibit specific steps in the viral reproduction. However, the pathogen rapidly develops resistance, becoming insensitive to these agents. Researchers at the Helmholtz Centre for Infection Research (HZI) in Braunschweig, in collaboration with colleagues from the TWINCORE in Hannover have discovered new drug leads that are also efficient against resistant virus. They present their work in the "Journal of Biological Chemistry".]]></content:encoded><pubDate>Fri, 09 Nov 2012 00:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/a_finger_pointing_the_way_to_new_hepatitis_c_medication/</guid></item><item><title>Feel-good hormone helps to jog the memory</title><link>http://www.dzne.de/en/about-us/public-relations/meldungen/2012/press-release-no-24.html</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/e84d165c84.png" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/e84d165c84.png" width="200"></span><br />The feel-good hormone dopamine improves long-term memory. This is the finding of a team lead by Emrah Düzel, neuroscientist at the German Center for Neurodegenerative Diseases (DZNE) and the University of Magdeburg. The researchers investigated test subjects ranging in age from 65 to 75 years, who were given a precursor of dopamine. Treated subjects performed better in a memory test than a comparison group, who had taken a placebo. The study provides new insights into the formation of long lasting memories and also has implications for understanding why memories fade more rapidly following the onset of Alzheimer’s disease. The results appear in the “Journal of Neuroscience”.]]></content:encoded><pubDate>Thu, 08 Nov 2012 00:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dzne.de/en/about-us/public-relations/meldungen/2012/press-release-no-24.html</guid></item><item><title>Special Award in "Idea Competition 2012" for Polymer researcher in Geesthacht</title><link>http://www.hzg.de/cms01/public_relations/press_releases/034598/index_0034598.html.en</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Innovative ideas "made in Schleswig-Holstein" were awarded on Thursday, 1st of November in the German National Library of Economics (ZBW) in Kiel. The 1000 Euro special award "nanotechnology" was received to the Geesthacht polymer researcher Prof. Dr.-Ing. Mady Elbahri.]]></content:encoded><pubDate>Tue, 06 Nov 2012 15:37:12 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.hzg.de/cms01/public_relations/press_releases/034598/index_0034598.html.en</guid></item><item><title>Prof. Walter Rosenthal: “The Founding of the Berlin Institute of Health: A Unique Opportunity for the German Science Landscape”</title><link>http://www.mdc-berlin.de/en/news/2012/20121106-prof__walter_rosenthal___the_founding_of_t/index.html</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[“The founding of the Berlin Institute of Health, (BIH) is a unique opportunity for the German science landscape to restructure the collaboration between a non-university research institution and a university medical center in the field of basic and clinical research,” said Prof. Walter Rosenthal, chairman of the board and scientific director of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch. Speaking at a press conference with Federal Research Minister Annette Schavan and Berlin’s Governing Mayor Klaus Wowereit in the Charité on November 6, 2012, he went on to say: “For politicians, German reunification was something unique, just as it was for me as a citizen. Something like that only happens once in a lifetime. And here in the field of science another once-in-a-lifetime opportunity has presented itself – to participate in the creation of an entirely new research structure. I am therefore delighted that we can be part of the founding of the BIH.]]></content:encoded><pubDate>Tue, 06 Nov 2012 01:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.mdc-berlin.de/en/news/2012/20121106-prof__walter_rosenthal___the_founding_of_t/index.html</guid></item><item><title>Prof. Walter Rosenthal: “The Founding of the Berlin Institute of Health: A Unique Opportunity for the German Science Landscape”</title><link>http://www.mdc-berlin.de/en/news/archive/2012/20121106-prof__walter_rosenthal___the_founding_of_t/index.html</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[“The founding of the Berlin Institute of Health, (BIH) is a unique opportunity for the German science landscape to restructure the collaboration between a non-university research institution and a university medical center in the field of basic and clinical research,” said Prof. Walter Rosenthal, chairman of the board and scientific director of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch. Speaking at a press conference with Federal Research Minister Annette Schavan and Berlin’s Governing Mayor Klaus Wowereit in the Charité on November 6, 2012, he went on to say: “For politicians, German reunification was something unique, just as it was for me as a citizen. Something like that only happens once in a lifetime. And here in the field of science another once-in-a-lifetime opportunity has presented itself – to participate in the creation of an entirely new research structure. I am therefore delighted that we can be part of the founding of the BIH.]]></content:encoded><pubDate>Tue, 06 Nov 2012 01:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.mdc-berlin.de/en/news/archive/2012/20121106-prof__walter_rosenthal___the_founding_of_t/index.html</guid></item><item><title>Max Delbrück Center and Charité pool their research activities</title><link>http://www.helmholtz.de/en/press/press_releases/artikel/artikeldetail/max_delbrueck_centrum_und_charite_vereinen_forschungsaktivitaeten/</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[The Federal Minister of Education and Research, Prof. Annette Schavan, announced today in the presence of the Governing Mayor of Berlin, Klaus Wowereit, that researchers at the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch, a member of the Helmholtz Association, and the Charité – Universitätsmedizin Berlin will be working together under one roof in the future. The Helmholtz Association regards this fusion of two top-level research institutes as a major step forward in the future development of the German research system.]]></content:encoded><pubDate>Tue, 06 Nov 2012 00:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.helmholtz.de/en/press/press_releases/artikel/artikeldetail/max_delbrueck_centrum_und_charite_vereinen_forschungsaktivitaeten/</guid></item><item><title>Scientists Find Achilles Heel of Cancer Cells</title><link>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-56-Scientists-Find-Achilles-Heel-of-Cancer-Cells.php</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum) and Heidelberg University Hospital have identified the HDAC11 enzyme as a promising target for new cancer therapies. If this molecule is turned off, cancer cells stop growing and die. Normal cells, however, are not affected by blocking HDAC11. The researchers are now looking for compounds that block selectively HDAC11.]]></content:encoded><pubDate>Mon, 05 Nov 2012 09:50:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-56-Scientists-Find-Achilles-Heel-of-Cancer-Cells.php</guid></item><item><title>KIT Nanotechnology – A Model for China</title><link>http://www.kit.edu/visit/pi_2012_12209.php</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[The Chinese Nanjing University of Science and Technology is establishing a nanoscience institute using the Institute of Na-notechnology (INT) of Karlsruhe Institute of Technology (KIT) as a model. The new institute is named after and will be headed by Professor Herbert Gleiter. The co-founder and former director of INT, where he is still conducting research, is a pioneer of nanosciences worldwide. At the Herbert Gleiter Institute of Nanoscience, five research groups will be established, of which four will be headed by leading INT nanoscientists.]]></content:encoded><pubDate>Fri, 02 Nov 2012 11:08:57 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.kit.edu/visit/pi_2012_12209.php</guid></item><item><title>Geoscientist Dr Juliane Müller is awarded the German Study Prize for her pioneering climate research</title><link>http://www.awi.de/en/news/press_releases/detail/item/geowissenschaftlerin_dr_juliane_mueller_erhaelt_den_deutschen_studienpreis_fuer_ihre_wegweisende_kl/?cHash=b5d1433288dc5f28783aa23f14550a5e</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Dr Juliane Müller will be awarded a second place in the German Study Prize on 6 November in Berlin. The Körber Foundation honours the geoscientist from the Alfred Wegener Institute for Polar and Marine Research in the Helmholtz Association for her pioneering PhD thesis on sea ice distribution.]]></content:encoded><pubDate>Fri, 02 Nov 2012 10:14:03 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.awi.de/en/news/press_releases/detail/item/geowissenschaftlerin_dr_juliane_mueller_erhaelt_den_deutschen_studienpreis_fuer_ihre_wegweisende_kl/?cHash=b5d1433288dc5f28783aa23f14550a5e</guid></item><item><title>New Findings on Gene Regulation and Bone Development</title><link>http://www.mdc-berlin.de/en/news/archive/2012/20121102-new_findings_on_gene_regulation_and_bone_d1/index.html</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[  The patients have single short fingers (metacarpals) and toes (metatarsals) and can be restricted in growth due to a shortened skeleton. This hereditary disease is called brachydactyly type E (Greek for short fingers). Three years ago Dr. Philipp G. Maass from the research group of Professor Friedrich C. Luft at the Experimental and Clinical Research Center (ECRC), a joint cooperation between the Charité Medical Faculty and the Max Delbrück Center for Molecular Medicine (MDC) in Berlin-Buch, has discovered an epigenetic mechanism, which, when dysregulated, causes this condition. Now, together with Dr. Sylvia Bähring (ECRC) he was able to show how this epigenetic regulator functions and influences the development of the skeleton and the extremities. Also, he shed light on a new principle of gene regulation (Journal of Clinical Investigation, doi: 10.1172/JCI65508)*.]]></content:encoded><pubDate>Fri, 02 Nov 2012 01:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.mdc-berlin.de/en/news/archive/2012/20121102-new_findings_on_gene_regulation_and_bone_d1/index.html</guid></item><item><title>Stronger cooperation with Oman</title><link>http://www.helmholtz.de/en/press/press_releases/artikel/artikeldetail/kooperation_mit_oman_gestaerkt/</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/022a5725b0.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/022a5725b0.jpg" width="200"></span><br />Representatives of the Helmholtz Association and The Research Council (TRC), Oman’s research funding body, signed an agreement in Berlin last night in which they reiterated their plans to build a technology centre in Oman. Research at the new institute will focus on improved oil and gas extraction, water resources technology and renewable energies. Four Helmholtz centres are involved in this cooperation so far: GEOMAR Helmholtz Centre for Ocean Research Kiel, the Helmholtz Centre Potsdam ‒ German Research Centre for Geosciences (GFZ), the Helmholtz Centre for Environmental Research - UFZ and the German Aerospace Center (DLR).]]></content:encoded><pubDate>Wed, 31 Oct 2012 00:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.helmholtz.de/en/press/press_releases/artikel/artikeldetail/kooperation_mit_oman_gestaerkt/</guid></item><item><title>Tumor Analysis in Cerebrospinal Fluid  400,000 for Pediatric Brain Cancer Research</title><link>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-55-Tumor-Analysis-in-Cerebrospinal-Fluid.php</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Researchers from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) plan to develop a technique that will enable them to detect pediatric brain tumors in cerebrospinal fluid. The biology and extent of the cancers – both decisive factors in determining therapeutic choices – will also be assessed using this method. The James S. McDonnell Foundation will provide funds of almost half a million US dollars to support the project led by Professor Dr. Stefan Pfister.]]></content:encoded><pubDate>Tue, 30 Oct 2012 14:49:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-55-Tumor-Analysis-in-Cerebrospinal-Fluid.php</guid></item><item><title>New International Forum for Heavy Metal Research</title><link>http://www.hzdr.de/db/Cms?pNid=99&amp;pOid=37858</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Ein neues internationales Forum für den Austausch zwischen experimenteller und theoretischer Forschung auf dem Gebiet radioaktiver Schwermetalle (Aktinide) findet vom 5. bis 7. November 2012 am HZDR statt.]]></content:encoded><pubDate>Tue, 30 Oct 2012 00:00:00 +0100</pubDate><category>HZDR</category><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.hzdr.de/db/Cms?pNid=99&amp;pOid=37858</guid></item><item><title>Nationwide Alliance Against Cancer</title><link>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-54-Nationwide-Alliance-Against-Cancer.php</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[With the attendance of Germany´s Federal Minister Professor Dr. Annette Schavan and State Minister Theresia Bauer, the official launch of the German Consortium for Translational Cancer Research (DKTK) was celebrated today in Heidelberg.]]></content:encoded><pubDate>Mon, 29 Oct 2012 14:28:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-54-Nationwide-Alliance-Against-Cancer.php</guid></item><item><title>Winter experiment planned in the Antarctic ice: the research vessel Polarstern leaves for the South Polar Sea on an 18-month long expedition</title><link>http://www.awi.de/en/news/press_releases/detail/item/winter_experiment_in_antarctic_sea_ice_planned/?cHash=432a0ddcaadc4e31a288cbe19f4d52a4</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[The research ship POLARSTERN sets off in the early morning hours of 27 October 2012 for an unusual expedition to the Antarctic. This time the ship will not be returning to Bremerhaven as usual at the end of the Antarctic summer, but will be spending the winter in the South Polar Sea for research purposes.]]></content:encoded><pubDate>Fri, 26 Oct 2012 09:13:32 +0200</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.awi.de/en/news/press_releases/detail/item/winter_experiment_in_antarctic_sea_ice_planned/?cHash=432a0ddcaadc4e31a288cbe19f4d52a4</guid></item><item><title>Targeted dissolution: the new generation of implants</title><link>http://www.hzg.de/cms01/public_relations/press_releases/034437/index_0034437.html.en</link><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Is a paradigm shift imminent in the field of implant materials? Scientists at the Helmholtz Zentrum Geesthacht are engaged in research on biodegradable magnesium biomaterials which can be used as bone replacements in medical applications. They will present their research results from the 1st to 3rd November at the annual congress of the DGBM (German society for Biomaterials) in Hamburg.]]></content:encoded><pubDate>Fri, 26 Oct 2012 08:55:30 +0200</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.hzg.de/cms01/public_relations/press_releases/034437/index_0034437.html.en</guid></item><item><title>Triclosan needs to be monitored</title><link>http://www.ufz.de/index.php?en=30926</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/f750fd1d90.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/f750fd1d90.jpg" width="200"></span><br />Researchers from Germany and Slovakia have pointed out that the chemical triclosan is one of those particularly harmful substances for the ecological status of rivers that are still not sufficiently monitored. With extensive monitoring conducted in the Elbe river basin that was more comprehensive than standard monitoring procedures, concentrations of the chemical at numerous test sites exceeded the predicted no-effect concentration (PNEC) for algal communities up to a factor of twelve. From the 500 river basin-specific pollutants investigated, triclosan (normally used as an anti-bacterial agent) ranked sixth as one of the most particularly harmful substances in Europe. It is therefore imperative to include this substance in routine monitoring programmes at the European scale, according to what researchers from the Helmholtz Centre for Environmental Research (UFZ) and the Environmental Institute in Slovakia have written in the journal „Environmental Science Pollution Research“.]]></content:encoded><pubDate>Fri, 26 Oct 2012 02:00:00 +0200</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.ufz.de/index.php?en=30926</guid></item><item><title>7.5 Million Euros for the Fight Against Cancer</title><link>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-2012-7-5-Million-Euros-for-the-Fight-Against-Cancer.php</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/73e471685d.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&amp;cHash=e63839089e2421d4805ec1eb046c07b9" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/73e471685d.jpg" width="200"></span><br />The Dietmar Hopp Foundation will fund the Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM) at the German Cancer Research Center (DKFZ) for another five years.]]></content:encoded><pubDate>Thu, 25 Oct 2012 11:53:00 +0200</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-2012-7-5-Million-Euros-for-the-Fight-Against-Cancer.php</guid></item></channel></rss